The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Antipsychotic Drugs Market From 2026 To 2030?
The antipsychotic drugs market size has experienced robust growth over recent years. It is projected to expand from $21.25 billion in 2025 to $23.23 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. This historical growth can be linked to factors such as the introduction of first-generation antipsychotics, a rising awareness of mental health disorders, the expansion of hospital and clinical infrastructure, an increasing prevalence of schizophrenia and bipolar disorder, and enhanced research and development investments in neuropsychiatric drugs.
The antipsychotic drugs market is projected to experience substantial expansion in the coming years, with its size anticipated to reach $33.26 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This projected growth is primarily driven by several factors, including progress in atypical and partial dopamine agonists, the increasing adoption of precision medicine approaches, the integration of AI in mental health diagnostics, the expansion of online pharmacy distribution, and a heightened focus on long-acting injectable formulations. Key trends influencing this forecast period encompass personalized antipsychotic therapy, a rising geriatric population, the increasing prevalence of schizophrenia and bipolar disorder, the emergence of telepsychiatry and digital mental health platforms, and the continued development of long-acting injectable antipsychotics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18780&type=smp
What Drivers Are Influencing The Antipsychotic Drugs Market?
The antipsychotic drug market is anticipated to expand due to the increasing occurrence of mental disorders. These illnesses, which affect a person’s thoughts, actions, feelings, and overall mental well-being, can stem from factors such as stress, societal pressures, genetic tendencies, biochemical imbalances, neurodevelopmental issues, and physical health. Antipsychotic medications address mental disorders by modifying neurotransmitter activity, particularly dopamine and serotonin, which helps in alleviating psychotic symptoms, stabilizing mood, and enhancing cognitive and emotional capabilities. For example, a survey by SAMHSA, a US public health agency, indicated in November 2023 that roughly 6% of adults aged 18 or older, amounting to 15.4 million people, experienced serious mental illness (SMI). Additionally, the Australian Institute of Health and Welfare, an Australian government body, reported in September 2024 that the number of individuals with dementia in Australia is projected to more than double from approximately 411,100 in 2023 to 849,300 by 2058, impacting around 315,500 men and 533,800 women. Thus, the rising incidence of mental disorders is a key driver for the antipsychotic drug market.
Which Segments Are Included In The Analysis Of The Antipsychotic Drugs Market?
The antipsychotic drugs market covered in this report is segmented –
1) By Therapeutic Class: First Generation, Second Generation, Third Generation
2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases
3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies
Subsegments:
1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines
2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone
3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine
Which Trends Are Impacting The Growth Of The Antipsychotic Drugs Market?
Leading companies in the antipsychotic drug market are prioritizing the creation of advanced medical products, such as subcutaneous atypical antipsychotic injections, with the aim of boosting patient compliance and improving efficacy over traditional oral medications. These subcutaneous atypical antipsychotic injections are psychiatric medicines given under the skin to treat mental illnesses, maintain stable blood levels, and enhance symptom control. For instance, in April 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, and MedinCell SA, a France-based manufacturer of biological products and pharmaceutical preparations, introduced U.S. Food and Drug Administration (FDA)-approved UZEDY. This product is an extended-release injectable formulation of risperidone, engineered as a long-acting subcutaneous injection that provides flexible dosing intervals of one or two months. UZEDY employs MedinCell’s proprietary SteadyTeq technology, which guarantees a consistent release of the medication, reaching therapeutic levels within 6–24 hours of administration. Clinical trials indicated that UZEDY offered up to an 80% reduction in the risk of schizophrenia relapse compared to placebo. Its purpose is to resolve adherence challenges commonly linked with oral antipsychotics, which frequently contribute to relapse.
Which Key Industry Participants Are Active In The Antipsychotic Drugs Market?
Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc
Read the full antipsychotic drugs market report here:
https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Antipsychotic Drugs Market?
North America was the largest region in the antipsychotic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Antipsychotic Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18780&type=smp
Browse Through More Reports Similar to the Global Antipsychotic Drugs Market 2026, By The Business Research Company
Antipsychotic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report
Anticholinergic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report
Epilepsy Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/epilepsy-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model